Study Findings on Breast Cancer Discussed by Researchers at University of Notre Dame (Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer)

Press/Media

Period	27 Apr 2023

Media coverage

Title	Study Findings on Breast Cancer Discussed by Researchers at University of Notre Dame (Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer)
Media name/outlet	NewsRx Women's Health Daily
Country/Territory	United States
Date	27/04/23
URL	metabase.moreover.com/noarticleurl?type=psh&lni=683T-1BK1-DY7R-R436-00000-00
Persons	Ryan Neff